CoChat

Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Abstract

Human hematopoietic stem cells (HSCs) exposed to cytokines in vitro rapidly divide and lose their characteristic functional properties presumably due to the alteration of a genetic program that determines the properties of an HSC. We have attempted to reverse the silencing of this HSC genetic program by the sequential treatment of human cord blood CD34+ cells with the chromatin-modifying agents, 5-aza-2′-deoxycytidine (5azaD) and trichostatin A (TSA). We determined that all CD34+CD90+ cells treated with 5azaD/TSA and cytokines after 9 days of incubation divide, but to a lesser degree than cells exposed to only cytokines. When CD34+CD90+ cells that have undergone extensive number of cell divisions (5-10) in the presence of cytokines alone were transplanted into immunodeficient mice, donor cell chimerism was not detectable. By contrast, 5azaD/TSA-treated cells that have undergone similar numbers of cell divisions retained their marrow repopulating potential. The expression of several genes and their products previously implicated in HSC self-renewal were up-regulated in the cells treated with 5azaD/TSA as compared to cells exposed to cytokines alone. These data indicate that HSC treated with chromatin-modifying agents are capable of undergoing repeated cell divisions in vitro while retaining their marrow-repopulating potential.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2006-07-035287

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 65 references

Cited by

See all 102

Metadata

Authors
Araki, H., Yoshinaga, K., Boccuni, P., Zhao, Y., Hoffman, R., & Mahmud, N.
Affiliations
University of Illinois Chicago (US)
Venue
Blood
Published
2006-12-21
Volume
109
Issue
8
Pages
3570-3578
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2072808238
Cited by
98
References
62
Citations by year
2025: 3 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 7 · 2014: 6 · 2013: 6 · 2012: 12
FWCI
2.40
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
hematopoietic stem cells, decitabine, trichostatin A, umbilical cord blood, self-renewal, gene silencing, gene upregulation, donor chimerism
MeSH terms
Decitabine, Animals, Azacitidine, Cell Division, Cells, Cultured, Chromatin, Enzyme Inhibitors, Hematopoietic Stem Cells, Humans, Hydroxamic Acids, Time Factors, Transplantation, Heterologous, Up-Regulation, Cytokines, Mice, SCID, Mice, Inbred NOD, Hematopoietic Stem Cell Transplantation, Thy-1 Antigens, Antigens, CD34, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. https://app.cochat.ai/papers/10.1182/blood-2006-07-035287
The paper
Araki, H., Yoshinaga, K., Boccuni, P., Zhao, Y., Hoffman, R., & Mahmud, N. (2007). Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. Blood. https://doi.org/10.1182/blood-2006-07-035287

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.